Menu
No results found.
Weekly Share Price & Valuation Overview
Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
- Earnings growth ≥10% supports improving profitability trajectory.
- Market Cap Total equity value of the company (share price × shares outstanding).
- AUD 13.99B
- Enterprise Value Operating value: market cap + total debt − cash.
- AUD 17.99B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- AUD 9.33B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- AUD 3.08B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- AUD 1.26B
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- AUD 19.46
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 1.14
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 3.78%
- Shares Outstanding
- 494.24M
- Float Shares
- 454.70M
- Implied Shares Outstanding
- 494.24M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
9.33%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
13.46%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
33.05%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
5.85%
- ROA Return on assets: net income ÷ total assets.
-
4.01%
- ROE Return on equity: net income ÷ shareholder equity.
-
7.16%
- Revenue Growth Year-over-year revenue growth.
-
8.40%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
15.50%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
17.00%
- Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
- 0.86
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.58
- Total Cash Cash and equivalents.
- AUD 541.32M
- Total Debt Short + long-term interest-bearing debt.
- AUD 4.80B
- Net Debt Total debt − cash (negative = net cash).
- AUD 4.26B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 3.82
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- AUD 1.24B
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- AUD 680.49M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
13.29%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
7.29%
- Cash Conversion (OpCF/EBITDA)
- 0.99
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.